LEP and amyotrophic lateral sclerosis: Together, our results suggest that targeting the sTNF-RII/AMPK/leptin pathway in adipocytes may help restore metabolic homeostasis and potentially reduce the rate of decline in ALS patients with rapidly progressing disease.